Gefitinib-Induced Cutaneous Toxicities in Brown Norway Rats Are Associated with Macrophage Infiltration-Reference-Cited by-同舟云学术

Gefitinib-Induced Cutaneous Toxicities in Brown Norway Rats Are Associated with Macrophage Infiltration

Published:2020-10-06 Issue:6 Volume:43 Page:2137-2146
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Wan Liangqin,Wang Yalei,Tang Yibo,Tan Yan,He Fang,Zhang Yali,Yang Ke,Chen Ziwei,Song Chenchen,Gu Ruoxi,Zhang Ce,Wang Xu,Wei Peng,Liu Tonghua,Jiang Miao,Hua Qian^ORCID

Funder

Tibetan foundation projects

National Natural Science Foundation projects

New Teacher Initial Funding

National Center International Research

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s10753-020-01281-2.pdf

Reference26 articles.

1. Melosky, B., H. Anderson, R.L. Burkes, Q. Chu, D. Hao, V. Ho, C. Ho, W. Lam, C.W. Lee, N.B. Leighl, N. Murray, S. Sun, R. Winston, and J.J. Laskin. 2016. Pan Canadian rash trial: a randomized phase III trial evaluating the impact of a prophylactic skin treatment regimen on epidermal growth factor receptor-tyrosine kinase inhibitor-induced skin toxicities in patients with metastatic lung cancer. Journal of Clinical Oncology 34 (8): 810–815.

2. Odogwu, L., L. Mathieu, K.B. Goldberg, G.M. Blumenthal, E. Larkins, M.H. Fiero, L. Rodriguez, K. Bijwaard, E.Y. Lee, R. Philip, I. Fan, M. Donoghue, P. Keegan, A. McKee, and R. Pazdur. 2018. FDA benefit-risk assessment of osimertinib for the treatment of metastatic non-small cell lung cancer harboring epidermal growth factor receptor T790M mutation. Oncologist 23 (3): 353–359.

3. Qian, J., X. Zhang, B. Zhang, P. Gu, L. Wang, and B. Han. 2018. Hepatotoxicity in advanced lung adenocarcinoma: a retrospective study of 2108 cases. Journal of Cancer 9 (9): 1607–1613.

4. Monjazeb, S., and J. Wilson. 2017. Epidermal growth factor receptor inhibitors: cutaneous side effects and their management. Skin Therapy Letter 22 (5): 5–7.

5. Peus, D., L. Hamacher, and M.R. Pittelkow. 1997. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. Journal of Investigative Dermatology 109 (6): 751–756.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model;Recent Patents on Anti-Cancer Drug Discovery;2024-08

2. Integrating network pharmacology and experimental models to investigate the efficacy and mechanism of Tiansha mixture on xerosis;Archives of Dermatological Research;2024-07-13

3. Traditional Chinese Medicine Formulae QY305 Reducing Cutaneous Adverse Reaction and Diarrhea by its Nanostructure;Advanced Science;2023-12-03

4. Xijiao Dihuang decoction relieves the erlotinib-induced dermatitis;Experimental Cell Research;2023-02

5. Macrophage renewal modes affect acquired resistance to gefitinib in EGFR‑mutant lung cancer PC‑9 cells;Oncology Reports;2022-12-21